Skip to main content

Yu Fan

13F filer · CIK 0001668029
Reported Aug 14, 2026
13F portfolio value$108MU.S. long equity reported on 13F
Positions8Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 20268 positions
KMTSKestra Medical Technologies, Ltd.$58.1M53.81%3.91%Not reportedQ1 2025
WHWKWhitehawk Therapeutics, Inc.$22.3M20.63%8.53%+134.9%Q1 2025
ALMSAlumis Inc.$7.11M6.59%Not reported-67.5%Q2 2024
CBLLCeribell, Inc.$6.66M6.17%0.90%-37.7%Q4 2024
IVAInventiva S.A.$5.67M5.25%0.78%Not reportedQ4 2025
PMNProMIS Neurosciences Inc.$4.34M4.02%3.68%Not reportedQ1 2026
CATXPerspective Therapeutics, Inc.$3.6M3.33%0.93%Not reportedQ1 2026
ABTCAmerican Bitcoin Corp.$210K0.19%1.86%Not reportedQ1 2026
Q1 2026Reported May 18, 20268 positions
KMTSKestra Medical Technologies, Ltd.$45.5M46.89%3.91%Not reportedQ1 2025
ALMSAlumis Inc.$17.1M17.64%Not reported-1.6%Q2 2024
CBLLCeribell, Inc.$10.1M10.38%1.45%Not reportedQ4 2024
IVAInventiva S.A.$8.33M8.58%0.78%Not reportedQ4 2025
WHWKWhitehawk Therapeutics, Inc.$7.14M7.36%4.39%Not reportedQ1 2025
CATXPerspective Therapeutics, Inc.$4.4M4.54%0.93%NewQ1 2026
PMNProMIS Neurosciences Inc.$4.19M4.32%3.68%NewQ1 2026
ABTCAmerican Bitcoin Corp.$285K0.29%1.86%NewQ1 2026
Q4 2025Reported Feb 18, 20265 positions
KMTSKestra Medical Technologies, Ltd.$60.5M65.60%3.91%Not reportedQ1 2025
CBLLCeribell, Inc.$12M13.06%1.47%-59.4%Q4 2024
ALMSAlumis Inc.$7.71M8.35%Not reportedNot reportedQ2 2024
IVAInventiva S.A.$6.98M7.56%0.78%NewQ4 2025
WHWKWhitehawk Therapeutics, Inc.$5.01M5.43%4.39%Not reportedQ1 2025
Q3 2025Reported Nov 14, 20254 positions
KMTSKestra Medical Technologies, Ltd.$54.2M70.56%4.44%Not reportedQ1 2025
CBLLCeribell, Inc.$15.5M20.23%3.65%Not reportedQ4 2024
WHWKWhitehawk Therapeutics, Inc.$3.93M5.12%4.39%Not reportedQ1 2025
ALMSAlumis Inc.$3.15M4.10%Not reportedNot reportedQ2 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.